Literature DB >> 26184541

Uveitis in adults: What do rheumatologists need to know?

Pascal Sève1, Laurent Kodjikian2, Léopold Adélaïde3, Yvan Jamilloux3.   

Abstract

Rheumatologists may need to establish the etiological diagnosis and handle the therapeutic management of adults with uveitis. To date, no diagnostic strategy for uveitis has been validated by prospective studies. Investigations are selected based on the clinical features and on the anatomic location of the ocular abnormalities. Infections such as syphilis, Lyme disease, tuberculosis, and Whipple's disease may cause uveitis, with concomitant joint inflammation in a few cases. In patients with a known history of chronic inflammatory joint disease, causes of uveitis include bisphosphonate therapy and immunodepression-related infections (e.g., due to Toxoplasma or a herpes virus). Sarcoidosis is an underestimated cause of uveitis, which occurs in 15% of cases, with a predilection for middle-aged women. In spondyloarthritis, uveitis is almost always acute, unilateral, and anterior. Among patients with uveitis and spondyloarthritis, about two thirds have their joint disease diagnosed during an evaluation for uveitis. Therefore, patients with inflammatory or noninflammatory back pain should be routinely evaluated for spondyloarthritis, which is the leading cause of uveitis in western countries. The risk of blindness is extremely low, and the main complication is recurrent uveitis, seen in 50% to 60% of cases. Sulfasalazine decreases the frequency, duration, and severity of uveitis and can be used prophylactically.
Copyright © 2015. Published by Elsevier SAS.

Entities:  

Keywords:  Sarcoidosis; Spondyloarthritis; Sulfasalazine; TNFα antagonists; Uveitis

Mesh:

Year:  2015        PMID: 26184541     DOI: 10.1016/j.jbspin.2015.06.002

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  7 in total

Review 1.  IL-6 blockade in the management of non-infectious uveitis.

Authors:  Giuseppe Lopalco; Claudia Fabiani; Jurgen Sota; Orso Maria Lucherini; Gian Marco Tosi; Bruno Frediani; Florenzo Iannone; Mauro Galeazzi; Rossella Franceschini; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2017-05-20       Impact factor: 2.980

Review 2.  A Review of the Various Roles and Participation Levels of B-Cells in Non-Infectious Uveitis.

Authors:  Lei Zhu; Binyao Chen; Wenru Su
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

Review 3.  Clinical manifestations of Whipple's disease mimicking rheumatic disorders.

Authors:  Eugeniusz J Kucharz; Justyna Kramza; Anida Grosicka; Robert Pieczyrak
Journal:  Reumatologia       Date:  2021-04-27

Review 4.  The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future.

Authors:  Martina Biggioggero; Chiara Crotti; Andrea Becciolini; Elisabetta Miserocchi; Ennio Giulio Favalli
Journal:  Biomed Res Int       Date:  2018-10-14       Impact factor: 3.411

Review 5.  Uveitis as a Predictor of Predisposition to Autoimmunity.

Authors:  Jillian A Leibowitz; Arden T Woods; Marc M Kesselman; Bindu S Mayi
Journal:  Cureus       Date:  2020-03-28

6.  Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review.

Authors:  Ji Wen; Huifang Hu; Menglin Chen; Hang Yang; Yi Zhao; Yi Liu
Journal:  J Immunol Res       Date:  2021-12-20       Impact factor: 4.818

Review 7.  Biotherapies in Uveitis.

Authors:  Mathilde Leclercq; Anne-Claire Desbois; Fanny Domont; Georgina Maalouf; Sara Touhami; Patrice Cacoub; Bahram Bodaghi; David Saadoun
Journal:  J Clin Med       Date:  2020-11-08       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.